Table 3 Levels of proADM, proANP and copeptin in patients with mild, moderate and severe OSA, as assessed by the AHI, at baseline
Baseline Levels | OSA severity | p-value (Kruskal -Wallis Test) | ||
|---|---|---|---|---|
Mild OSA (N = 86) 5 ≤ AHI < 15 | Moderate OSA (N = 78) 15 ≤ AHI < 30 | Severe OSA (N = 68) AHI ≥ 30 | ||
proADM (nmol/l) | 0.60 (0.50–0.74) | 0.62 (0.55–0.75) | 0.63 (0.59–0.79) | p = 0.222 |
proANP (pmol/l) | 55.34 (42.61–79.64) | 54.81 (40.3–85.05) | 61.04 (44.77–98.37) | p = 0.672 |
Copeptin (pmol/l) | 7.15 (4.57–10.37) | 7.37 (5.3–9.64) | 7.92 (5.08–12.81) | p = 0.375 |